Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

AutoImmune and Teva to collaborate on oral immune therapies

Feb. 25, 1999

Status updated for Esteve's atypical antipsychotic E-5842

Feb. 25, 1999

New compounds from Pharmacia & Upjohn interfere in the kynurenine metabolic pathway

Feb. 25, 1999

Orphan Medical begins Treatment IND trial of Xyrem in narcolepsy

Feb. 25, 1999

Apollo and AHP to develop estrogen products for Alzheimer's therapy

Feb. 24, 1999

Soluble peptide complex AG-284 is well tolerated in MS patients

Feb. 24, 1999

Combination pharmaco- and psychotherapy reduces recurrence of depression in elderly

Feb. 24, 1999

Synthelabo patents potent and selective nAChR ligands

Feb. 24, 1999

New combination treatment for pain now available in U.S.

Feb. 23, 1999

V2 antagonist OPC-31260 prevents cerebral edema in rat model

Feb. 23, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 30, 2026.
New schizophrenia targets challenge trial design
BioWorld
The search for better schizophrenia therapies is moving beyond dopamine toward a growing number of experimental targets. According to researchers, the repeated...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 28, 2026
AIDS 2026: New targets for metabolic dysfunction despite ART
BioWorld
Although antiretroviral therapy (ART) can suppress HIV to undetectable levels, a growing body of evidence suggests that the virus leaves a lasting biological...
Taiwan biotech looks outward in next phase of growth
BioWorld
Taiwan’s biotechnology sector was built around domestic health needs, including vaccines and drug manufacturing, but it is increasingly looking outward – to...